<DOC>
	<DOCNO>NCT01843413</DOCNO>
	<brief_summary>This phase I/II trial study side effect best dose stereotactic radiosurgery see well work treat patient large brain metastasis . Radiosurgery send x-ray directly tumor cause less damage normal tissue .</brief_summary>
	<brief_title>Stereotactic Radiosurgery Treating Patients With Large Brain Metastases</brief_title>
	<detailed_description>PRIMARY OBJECTIVES : I . To determine incidence acute long-term toxicity increase dose stereotactic radiosurgery ( SRS ) . ( Phase I ) II . To determine local control may improve increase dos SRS . ( Phase II ) SECONDARY OBJECTIVES : I . To determine risk acute long-term toxicity increase dose SRS . ( Phase II ) II . To determine increase neurocognitive toxicity increase dose SRS . III . To determine rate radiation necrosis/steroid dependency . IV . To determine quality life affect tumor recurrence versus radiation necrosis . This include assessment progression free survival , overall survival , local failure , number patient receive bevacizumab , laser interstitial thermal therapy , surgery presume radiation necrosis . OUTLINE : This phase I dose-escalation study follow phase II study . Patients undergo SRS guide computer tomography ( CT ) magnetic resonance imaging ( MRI ) . After completion treatment , patient follow 1-2 , 3 , 6 , 9 , 12 month , every 3 month 2 year , every 4 month thereafter .</detailed_description>
	<mesh_term>Neoplasms</mesh_term>
	<criteria>Any patient undergoing SRS brain metastasis Lesions treat protocol must &gt; 2 cm , = &lt; 4.0 cm diameter Patients may prior therapy include : Whole brain radiation therapy ( WBRT ) &gt; 3 month ago SRS brain metastasis Patients newly diagnose brain metastasis eligible long plan WBRT upfront Any primary eligible exception small cell lung cancer , lymphoma , germ cell histology Patient must able provide write informed consent Patients receive SRS resection bed Planned concurrent WBRT Leptomeningeal metastases Small cell lung cancer , lymphoma , germ cell histology Inability participate study activity due physical mental limitation Inability unwillingness return require followup visit Conformality index 2.0 less achieve , homogeneity index &gt; 2.0 Unable deliver 10 Gray ( Gy ) less optic nerve/chiasm Brainstem location exclude study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>unspecified adult solid tumor , protocol specific</keyword>
</DOC>